Deciphering the biological questions of mycobacterium tuberculosis An in silico insight
Identification of drug targets in mycobacterium tuberculosis using proteomics based approaches
Identification of new molecular inhibitors for novel targets of Mycobacterium tuberculosis an in silico approach
